G21.11 Neuroleptic induced parkinsonism
Instructional Notes:
-
G21.11
Description: Neuroleptic induced parkinsonism
Exclude1:
- malignant neuroleptic syndrome (G21.0)
Use Additional Code:
- code for adverse effect, if applicable, to identify drug (T43.3X5, T43.4X5, T43.505, T43.595)
↓
-
G21.1
Description: Other drug-induced secondary parkinsonism
↓
-
G21
Description: Secondary parkinsonism
Exclude1:
- Huntington's disease (G10)
- neurocognitive disorder with Lewy bodies (G31.83)
- Shy-Drager syndrome (G90.3)
- syphilitic Parkinsonism (A52.19)
↓
-
G20-G26
Description: Extrapyramidal and movement disorders (G20-G26)
↓
-
G00-G99
Description: Diseases of the nervous system
Exclude2:
- certain conditions originating in the perinatal period (P04-P96)
- certain infectious and parasitic diseases (A00-B99)
- complications of pregnancy, childbirth and the puerperium (O00-O9A)
- congenital malformations, deformations, and chromosomal abnormalities (Q00-Q99)
- endocrine, nutritional and metabolic diseases (E00-E88)
- injury, poisoning and certain other consequences of external causes (S00-T88)
- neoplasms (C00-D49)
- symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified (R00-R94)